Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

See all formats and pricing
In This Section
Volume 41, Issue 11 (Nov 2003)


The Role of Genetic Factors in the Development of Hyperhomocysteinemia

Jürgen Geisel / Ulrich Hübner / Marion Bodis / Heike Schorr / Jean-Pierre Knapp / Rima Obeid / Wolfgang Herrmann
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.219


Moderate hyperhomocysteinemia has been identified as a new independent risk factor for cardiovascular and neurodegenerative diseases. This fact has produced interest in the study of genetic variants involved in homocysteine metabolism and its relationship to pathogenesis. Recently, more than 15 different genes were studied for their relationship to plasma homocysteine levels. We determined the influence of genetic variants in five genes (5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T, serine hydroxymethyltransferase (SHMT) 1420C→T, thymidylate synthase (TS) 2R→3R, catechol-O-methyltransferase (COMT) 1947G→A and transcobalamin (TC) 776C→G) on plasma homocysteine, folic acid and parameters of vitamin B12 metabolism in 111 vegetarians (mean age: 46±15 years) and 118 healthy seniors (mean age: 82±6.5 years). Median homocysteine concentration in plasma was significantly influenced by the MTHFR genotypes in both populations. In the vegetarians the median homocysteine level was increased by 8 μmol/l in individuals homozygous for the mutation as compared to wild-type or heterozygous genotypes (20.4 μmol/l vs. 12.9 and 12.7 μmol/l, respectively). This unexpected increase was observed although the folate levels were in medium to elevated ranges. Our results suggest that vegetarians have a higher demand for folate to neutralize the genotype effect. Preclinical vitamin B12 deficiency in vegetarians may be the cause for disturbed remethylation and folate trap. Plasma homocysteine was not significantly influenced by the SHMT, TS, COMT and TC mutations. In addition, for the TC mutation a trend toward cellular vitamin B12 deficiency was observed. The methylmalonic acid (MMA) levels were slightly elevated and the holotranscobalamin-II (holoTC-II) levels decreased. In the vegetarian group a significant relationship between the COMT genotype and holoTC-II concentration in plasma was determined, whereas the high activity COMT genotype (G/G) resulted in increased levels (35 μmol/l vs. 21 μmol/l for heterozygous and low activity genotypes). The MMA levels were inversely correlated to holoTC-II concentrations. In conclusion, the study on vegetarians and seniors documents interesting lifestyle-genotype interactions. Although the TC and COMT mutations influence cellular vitamin B12 metabolism, this effect did not result in overt homocysteine elevation.

About the article

Published Online: 2005-06-01

Published in Print: 2003-11-17

Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.219. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Andreas Reif, Bruno Pfuhlmann, and Klaus-Peter Lesch
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2005, Volume 29, Number 7, Page 1162
G. Fiorito, S. Guarrera, C. Valle, F. Ricceri, A. Russo, S. Grioni, A. Mattiello, C. Di Gaetano, F. Rosa, F. Modica, L. Iacoviello, G. Frasca, R. Tumino, V. Krogh, S. Panico, P. Vineis, C. Sacerdote, and G. Matullo
Nutrition, Metabolism and Cardiovascular Diseases, 2014, Volume 24, Number 5, Page 483
A.O. Akanji, J.U. Ohaeri, S.A. Al-Shammri, and H.R. Fatania
Clinical Biochemistry, 2007, Volume 40, Number 13-14, Page 1026
Helge Frieling, Konstanze D. Römer, Sabine Beyer, Thomas Hillemacher, Julia Wilhelm, Georg Ernst Jacoby, Martina de Zwaan, Johannes Kornhuber, and Stefan Bleich
Journal of Psychiatric Research, 2008, Volume 42, Number 1, Page 83
D. Gaysina, S. Cohen, N. Craddock, A. Farmer, F. Hoda, A. Korszun, M. J. Owen, I.W. Craig, and P. McGuffin
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008, Volume 147B, Number 6, Page 699
A. Görkem Mungan, Murat Can, Serefden Açikgöz, Emel Eştürk, and Cevdet Altinyazar
Clinical Chemical Laboratory Medicine, 2006, Volume 44, Number 9
Ivon J. M. van der Linden, Lydia A. Afman, Sandra G. Heil, and Henk J. Blom
Proceedings of the Nutrition Society, 2006, Volume 65, Number 02, Page 204
Yuehua Huang, Zhi-Yong Lu, Karen S. Brown, Alexander S. Whitehead, and Ian A. Blair
Biomedical Chromatography, 2007, Volume 21, Number 1, Page 107
Isa Picerno, Cristina Chirico, Salvatore Condello, Giuseppa Visalli, Nadia Ferlazzo, Gaetano Gorgone, Daniela Caccamo, and Riccardo Ientile
Biogerontology, 2007, Volume 8, Number 2, Page 111
R. Castro, I. Rivera, H. J. Blom, C. Jakobs, and I. Tavares de Almeida
Journal of Inherited Metabolic Disease, 2006, Volume 29, Number 1, Page 3
S J Lewis, D A Lawlor, G Davey Smith, R Araya, N Timpson, I N M Day, and S Ebrahim
Molecular Psychiatry, 2006, Volume 11, Number 4, Page 352
Martina Huemer, Bernd Ausserer, Gunther Graninger, Michael Hubmann, Christian Huemer, Kurt Schlachter, Arthur Tscharre, Hanno Ulmer, and Burkhard Simma
Epilepsia, 2005, Volume 46, Number 10, Page 1677

Comments (0)

Please log in or register to comment.
Log in